483sOnline Subscribe

Search By Date Issued

Search By Category

Drug
Device
Clinical

Search By Company/

Clinical Investigator

Search By Region

Search By FDA Investigator

Search By Keyword

Log in to start searching through our library of thousands of 483s, or Subscribe Now to 483sOnline.com to uncover exactly what FDA Inspectors are thinking about. It’s your own personal pre-investigation intelligence tool that identifies exactly what investigators are focusing on so you can be prepared – before they show up.

Chemco Corp. - Feb. 12, 2019

Issue Date

Feb 12, 2019

Region

Southeast

Category

Drug
$117.00

Chemco Corp.

Contact Name

Eitelberg G. Montarroyos

Contact Title

Vice President of Operations

Form483 Address 1

4920 NW 165th St.

Form483 Address 2

Form483 City

Miami Lakes

Form483 State

FL

Form483 Postal

33014-6323

Form483 Country

United States

Inspection Range

Feb 01, 2019 - Feb 12, 2019

Pages

3

First Observation

Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the identity and strength of each active ingredient prior to release.
Investigator(s): Jennifer Lalama